Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.580
-0.130-2.28%
Volume:35.27M
Turnover:195.82M
Market Cap:104.25B
PE:36.74
High:5.630
Open:5.605
Low:5.440
Close:5.710
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.58
T/O Rate:0.19%
Dividend:0.12
Dividend Rate:2.15%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.74
PE(LYR):36.74
PS:2.64

Loading ...

Innovative Drug TQB3454 from SBP Group's Subsidiary Seeks Market Approval in China

Stock News
·
Jul 10

Sino Biopharm Says China Regulator Accepts NDA for Tqb3454 IDH1 Inhibitor in Biliary Tract Cancer

Reuters
·
Jul 10

Sino Biopharmaceutical - China's Cde Accepts Nda for Tqb3454 Tablet 'idh1 Inhibitor' for Advanced BTC with Idh1 Mutations

THOMSON REUTERS
·
Jul 10

Sino Biopharmaceutical Stock Advances 3.8% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 10

Stock Track | Sino Biopharmaceutical Soars 5.00% Intraday on AstraZeneca and GSK Partnerships and NDA Milestone

Stock Track
·
Jul 10

Movement Alert|Sino Biopharmaceutical Rises 3.2% in Regular Trading, AstraZeneca and GSK Dual Partnerships Continue to Boost Sentiment

Market Focus
·
Jul 10

Why Sino Biopharmaceutical (SEHK:1177) Is Up 8.2% After New Global Respiratory Deals And NDA Milestone

Simply Wall St.
·
Jul 10

Sino Biopharmaceutical Stock Rises 3.7% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 09

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Deep News
·
Jul 09

Stock Track | SBP GROUP Soars 5.19% Intraday on AstraZeneca and GSK Licensing Deals

Stock Track
·
Jul 09

CMB International Reaffirms Buy Rating for SBP Group with HK$8.70 Price Target

Stock News
·
Jul 09

Movement Alert|Sino Biopharmaceutical Rises 4.15% in Regular Trading, AstraZeneca and GSK Dual Partnerships Continue to Boost Sentiment

Market Focus
·
Jul 09

PRESS Digest -wall Street Journal - July 8

Reuters
·
Jul 08

UK Stocks-factors to Watch on July 8

Reuters
·
Jul 08

Sino Biopharma Unit Licenses Respiratory Drug Candidate to AstraZeneca in Up to $2.1 Billion Deal

MT Newswires Live
·
Jul 08

SBP Group Expands GSK Partnership; Secures China Rights for Blockbuster Respiratory Drugs Trelegy Ellipta and Anoro Ellipta

Bulletin Express
·
Jul 08

Hong Kong Market Midday Report: Hang Seng Index Gains 2.38%, Domestic Chip Stocks Surge

Stock News
·
Jul 08

Sino Biopharma Deepens GSK Tie, Wins China Commercialization Rights for Trelegy and Anoro Inhalers

Reuters
·
Jul 08

Sino Biopharmaceutical - Sbp Group Deepens Exclusive Strategic Collaboration with GSK for Respiratory Therapies in China

THOMSON REUTERS
·
Jul 08

Sino Biopharmaceutical - Co Will be Responsible for Importation, Distribution, Others for These Products in Mainland China

THOMSON REUTERS
·
Jul 08